Niger
Niger
Explore linked clinical trials.2 results · Page 1 of 1
5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Azithromycin for Child Survival in Niger II | Antimicrobial Resistance; Mortality | Recruiting | Phase 4 | 2026-08-17 | NCT06358872 | |
| Integrating the Guardian Spatial Emanator Within AVENIR II | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not applicable | 2026-07-22 | NCT07712263 | |
| OptiMAx Will Test Whether SQ-LNS Incentivises Vaccination Uptake in Rural Chad and Niger, With a Cost Effectiveness Analysis. It Will Also Look at Whether Having Received SQ-LNS Before Becoming Malnourished Leads to Better Outcomes for Children Treated Under the OptiMA Protocol. | Malnutrition Severe; Vaccination | Recruiting | Not applicable | 2026-05-18 | NCT07592260 | |
| Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa | childhood malignant neoplasm, neoplasm | Recruiting | Not stated | 2025-10-03 | NCT03803735 | |
| Novel Triple-dose Tuberculosis Retreatment Regimen | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, multidrug-resistant tuberculosis, mycobacterial infectious disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 3 | 2025-04-13 | NCT04260477 |